S
Sean Pinney
Researcher at University of Chicago
Publications - 231
Citations - 6762
Sean Pinney is an academic researcher from University of Chicago. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 35, co-authored 187 publications receiving 4711 citations. Previous affiliations of Sean Pinney include Cardiovascular Institute of the South & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
Anuradha Lala,Anuradha Lala,Kipp W. Johnson,James L. Januzzi,Adam Russak,Ishan Paranjpe,Felix Richter,Shan Zhao,Sulaiman Somani,Tielman Van Vleck,Akhil Vaid,Fayzan Chaudhry,Jessica K De Freitas,Zahi A. Fayad,Sean Pinney,Matthew A. Levin,Alexander W. Charney,Emilia Bagiella,Jagat Narula,Benjamin S. Glicksberg,Girish N. Nadkarni,Donna M. Mancini,Valentin Fuster +22 more
TL;DR: Cardiovascular disease (CVD) including coronary artery disease, atrial fibrillation, and heart failure, was more prevalent in patients with higher troponin concentrations, as were hypertension and diabetes.
Journal ArticleDOI
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy
Donna Mancini,Sean Pinney,Daniel Burkhoff,John LaManca,Silviu Itescu,Elizabeth Burke,Niloo M. Edwards,Mehmet C. Oz,Andrew R. Marks +8 more
TL;DR: In this patient cohort with cardiac vasculopathy, treatment with rapamycin slowed disease progression probably by its antiproliferative and antimigratory effects.
Journal ArticleDOI
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device
James K. Kirklin,David C. Naftel,Robert L. Kormos,Francis D. Pagani,Susan L. Myers,Lynne W. Stevenson,Michael A. Acker,Daniel L. Goldstein,Scott C. Silvestry,Carmelo A. Milano,J.T. Baldwin,Sean Pinney,J. Eduardo Rame,Marissa A. Miller +13 more
TL;DR: Risk factor analysis suggests that a number of patient-related factors contribute to the risk of thrombosis, and that survival remains high (80% at 1 year) with the HMII LVAD.
Journal ArticleDOI
Characterization of Myocardial Injury in Patients With COVID-19.
Gennaro Giustino,Lori B. Croft,Giulio G. Stefanini,Renato Bragato,Jeffrey J. Silbiger,Marco Vicenzi,Tatyana Danilov,Nina Kukar,Nada Shaban,Annapoorna Kini,Anton Camaj,Solomon Bienstock,Eman Rashed,Karishma Rahman,Connor P. Oates,Samantha Buckley,Lindsay Elbaum,Derya Arkonac,Ryan Fiter,Ranbir Singh,Emily Li,Victor Razuk,Sam E. Robinson,Michael L. Miller,Benjamin Bier,Valeria Donghi,Marco Pisaniello,Riccardo Mantovani,Giuseppe Pinto,Irene Rota,Sara Baggio,Mauro Chiarito,Fabio Fazzari,Ignazio Cusmano,Mirko Curzi,Richard Ro,Waqas Malick,Mazullah Kamran,Roopa Kohli-Seth,Adel Bassily-Marcus,Eric Neibart,Gregory Serrao,Gila Perk,Donna M. Mancini,Vivek Y. Reddy,Sean Pinney,George Dangas,Francesco Blasi,Samin K. Sharma,Roxana Mehran,Gianluigi Condorelli,Gregg W. Stone,Valentin Fuster,Stamatios Lerakis,Martin E. Goldman +54 more
TL;DR: An international, multicenter cohort study including 7 hospitals in New York City and Milan of hospitalized patients with laboratory-confirmed COVID-19 who had undergone transthoracic echocardiographic (TTE) and electrocardiographic evaluation during their index hospitalization found cardiac structural abnormalities were present in nearly two-thirds of patients with myocardial injury.
Journal ArticleDOI
Venoarterial ECMO for Adults: JACC Scientific Expert Panel
Maya Guglin,Mark J. Zucker,Vanessa M. Bazan,Biykem Bozkurt,Aly El Banayosy,Jerry D. Estep,John C. Gurley,Karl E. Nelson,Rajasekhar Malyala,Gurusher Panjrath,Joseph B. Zwischenberger,Sean Pinney +11 more
TL;DR: As the use of this technology continues to evolve rapidly, it is important to understand the indications and contraindications; the logistics of ECMO initiation, management, and weaning; the general infrastructure of the program; and ethical considerations, areas of uncertainty, and future directions.